Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ Complex (DTC-Ln = alicyclic dithiocarbamate and PNP = Diphosphinoamine)

Bioconjugate Chemistry

Volumn 21, Issue 5, 2010, Pages 928-939

  Bolzati, Cristina ^a,b   Cavazza Ceccato, Mario ^b   Agostini, Stefania ^b   Refosco, Fiorenzo ^a   Yamamichi, Yoshihiro ^c   Tokunaga, Shinji ^c   Carta, Davide ^b   Salvarese, Nicola ^b   Bernardini, Daniele ^b   Bandoli, Giuliano ^b  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Nihon Medi Physics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; DITHIOCARBAMIC ACID DERIVATIVE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; TRACER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; FEMALE; HEART MUSCLE PERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LIVER LEVEL; LUNG; NONHUMAN; RADIOACTIVITY; RAT; TISSUE LEVEL;

RATTUS;

EID: 77952570263     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc900493e     Document Type: Article

References (38)

1. Llaurado, J. G. (2001) The quest for the perfect myocardial perfusion indicator... still a long way to go J. Nucl. Med. 42, 282-284
2. Schwaiger, M. and Melin, J. (1999) Cardiological applications of nuclear medicine Lancet 354, 661-666
3. Parker, J. A. (2001) Cardiac nuclear medicine in monitoring patients with coronary heart disease Semin. Nucl. Med. 31, 223-237
4. Kapur, A., Latus, K. A., Davies, G., Dhawan, R. T., Eastick, S., Jarritt, P. H., Roussakis, G., Young, M. C., Anagnostopoulos, C., Bomanji, J., Costa, D. C., Pennell, D. J., Prvulovich, E. M., Ell, P. J., and Underwood, R. S. (2002) A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study Eur. J. Nucl. Med. 29, 1608-1616
5. Kailasnath, P. and Sinusus, A. J. (2001) Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiological, and clinic issues J. Nucl. Cardiol. 8, 482-498
6. Pasqualini, R., Duatti, A., Bellande, E., Comazzi, V., Brucato, V., Hoffschir, D., Fagret, D., and Comet, M. (1994) Bis (dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: a class of neutral myocardial imaging agents J. Nucl. Med. 35, 334-341
7. 99mTc heterocomplexes as heart imaging agents with improved biological properties Nucl. Med. Commun. 23, 689-693
8. 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties J. Nucl. Med. 44, 806-814
9. Bolzati, C., Refosco, F., Cagnolini, A., Tisato, F., Boschi, A., Duatti, A., Uccelli, L., Dolmella, A., Marotta, E., and Tubaro, M. (2004) Synthesis, solution-state and solid-state structural characterization on monocationic nitrido heterocomplex [M(N)(DTC)(PNP)] + (M=99Tc, Re; DTC = dithiocarbammate; PNP = heterodiphosphine) Eur. J. Inorg. Chem. 9, 1902-1913
10. + J. Nucl. Med. 49, 1336-1344
11. 99mTc-Tetrofosmin in rats J. Nucl. Med. 45, 2095-2101
12. Hatada, K., Ruiz, M., Riou, L. M., Lima, R. L., Goode, A. R., Watson, D. D., Beller, G. A., and Glover, D. K. (2006) Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses J. Nucl. Cardiol. 6, 779-790
13. 99mTc-N-DBODC J. Nucl. Med. 49, 1299-1304
14. 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow Circulation 96, 2332-2338
15. Glover, D. K., Ruiz, M., Takehana, K., Petruzella, F. D., Riou, L. M., Rieger, J. M., Macdonald, T. L., Watson, D. D., Linden, J., and Beller, G. A. (2001) Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection Circulation 104, 1181-1187
16. 99mTc sestamibi uptake during adenosine-induced vasodilatation as a function of coronary stenosis severity Circulation 91, 813-820
17. Rumsey, W. L., Rosenspire, K. C., and Nunn, A. D. (1992) Myocardial extraction of teboroxime: effects of teboroxime interaction with blood J. Nucl. Med. 33, 94-101
18. 99mTc-N-NOET imaging for myocardial perfusion: can it offer more than we already have? J. Nucl. Med. 42, 1395-1396
19. Uccelli, L., Giganti, M., Duatti, A., Bolzati, C., Pasqualini, R., Cittanti, C., Colamussi, P., and Piffanelli, A. (1995) Subcellular distribution of technetium-99m-NOEt in rat myocardium J. Nucl. Med. 36, 2075-2079
20. 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow Circulation 96, 2325-2331
21. Narra, R. K., Nunn, A. D., Kuczynski, B. L., Feld, T., Wedeking, P., and Eckelman, W. C. (1989) A neutral Technetium-99m complex for myocardial imaging J. Nucl. Med. 30, 1830-1837
22. 99mTc-labelling small biomolecules Bioconjugate Chem. 17, 473-484
23. 99mTc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups Nucl. Med. Biol. 33, 419-432
24. 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging Nucl. Med. Biol. 33, 1045-1053
25. 99mTc-nitrido complexes Bioconjugate Chem. 18, 929-936
26. Fang, W., Liu, Y. J., Zhu, L., Kim, Y. S., Liu, S., and He, Z. X. (2008) Evaluation of (TcN)-Tc-99m-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis Nucl. Med. Com. 29, 775-781
27. Kim, Y. S., Wang, J. J., Broisat, A., Glover, D. K., and Liu, S. (2008) Tc-99m-N-MPO: Novel cationic Tc-99m radiotracer for myocardial perfusion imaging J. Nucl. Cardiol. 15, 535-546
28. Kim, Y. S., Shi, J. Y., Zhai, S. Z., Hou, G. H., and Liu, S. (2009) Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: A new perfusion radiotracer for heart imaging J. Nucl. Cardiol. 16, 571-579
29. 99mTc-complexes as potential brain imaging agents Bioconjugate Chem. 17, 419-428
30. Tisato, F., Refosco, F., Bolzati, C., Agostini, S., Porchia, M., Cavazza-Ceccato, M., and Tokunaga, S. (2006) Intermediate compound of technetium nitride complex for radiodiagnostic imaging, patent n PCT/JP2006/301260.
31. 2)chelate Appl. Radiat. Isot. 58, 543-549
32. Marmion, M. E., Woulfe, S. R., Neumann, W. L., Nosco, D. L., and Deutsch, E. (1999) Preparation and characterization of technetium complexes with Schiff base and phosphine coordination: Complexes of technetium-99g and -99m with substituted acac2en and trialkyl phosphines (where acac2en=N, NV-ethylenebis[acetylacetone iminato]) Nucl. Med. Biol. 26, 755-770
33. 3+ complexes containing ether analogs of DMPE Nucl. Med. Biol. 26, 563-571
34. 99mTcIII(DIARS)2(SR)2] + complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine), SR = thiolate) J. Med. Chem. 39, 1253-1261
35. Ford, J. M. and Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer Pharmacol. Rev. 42, 155-199
36. Gatmaitan, Z. C. and Arias, I. M. (1993) Structure and function of P-glycoprotein in normal liver and small intestine Adv. Pharmacol. 24, 77-97
37. Fricker, G. and Miller, D. S. (2002) Relevance of mutidrug resistance protein for intestinal drug absorption in vitro and in vivo Pharmacol. Toxicol. 90, 5-13
38. 99mTc-(N)-DBODC5 from cardiology to oncology. Preliminary in vitro study [PW142] Eur. J. Nucl. Med. Mol. Imaging 36 (Suppl 2) S309